The line-up of speakers is now confirmed for the SLAS2024 Ignite Theater: ‘Innovation & technology: from lab to patient’, curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation.

The event will take place on 5 and 6 February 2024 at SLAS in Boston, and will present leading research from experts in academia, government agencies and industry on how technology is innovating from bench to bedside, lab to patient.

Register now to show your interest.

The first speaker in the DDW track will be Dipanwita Das, CEO of Sorcero, answering the question ‘Is pharma’s commercial model dying?’ on Monday 5 February at 11.30am.

She will be followed by Andrea Bortolato, Director of Drug Discovery at SandboxAQ, at 3pm, who will speak on ‘Combining physics-based methods with AI solutions to maximise the probability of success and speed of drug discovery and development’.

At 3.30pm, Simon Bushell, SVP of Molecular Discovery at Entact Bio, will share his experience on ‘Proximity-inducing drugs: Using technological innovation to build the next generation of medicine’.

On Tuesday 6 February at 11.30am, attendees will hear on the topic ‘Structural vaccinology for influenza’ from Masaru Kanekiyo, Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC) at the US National Institute of Allergy and Infectious Diseases (NIAID).

Isaac Bentwich, Founder and CEO of Quris-AI, named one of the World’s Most Innovative Companies for 2023, will discuss ‘How AI and patient-on-chip are improving drug discovery and development’ at 3pm.

‘Accelerating biotherapeutics development through technology platforms’ will be addressed by Anubhav Tripathi, Professor of Medical Science and Engineering at Brown University at 3.30pm.

Register now to show your interest.